The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to biologics regulatory affairs outsourcing market will
help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of
25.9% in
2023.
Horizon Databook has segmented the Global biologics regulatory affairs outsourcing market based on legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services, regulatory consulting covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Biologics Regulatory Affairs Outsourcing Services Outlook (Revenue, USD Million, 2018-2030)
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Regulatory Consulting
- Strategy & Development Planning
- QA Consulting
- Agent Services
- Others
- Global Biologics Regulatory Affairs Outsourcing Phase Outlook (Revenue, USD Million, 2018-2030)
- Preclinical
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Global Biologics Regulatory Affairs Outsourcing Phase By Service Outlook (Revenue, USD Million, 2018-2030)
- Preclinical
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Clinical
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Global Biologics Regulatory Affairs Outsourcing Modality Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Cell & Gene Therapies
- Biosimilars
- Others
- Global Biologics Regulatory Affairs Outsourcing Phase by Modality Outlook (Revenue, USD Million, 2018-2030)
- Preclinical
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Cell & Gene Therapies
- Biosimilars
- Others
- Clinical
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Cell & Gene Therapies
- Biosimilars
- Others
- Global Biologics Regulatory Affairs Outsourcing Modality by Services Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal Antibodies (mAbs)
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Recombinant Proteins
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Vaccines
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Cell & Gene Therapies
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Biosimilars
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Others
- Regulatory Consulting
- Legal Representation
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Regulatory Operations
- Other Services
Reasons to
subscribe to Global biologics regulatory affairs outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global biologics regulatory affairs outsourcing market databook
-
Our clientele includes a mix of biologics regulatory affairs outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global biologics regulatory affairs outsourcing market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global biologics regulatory affairs outsourcing market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.